Xiaflex 0.9 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCFL7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,793
Award facts
- Contract value 100% obligated
- $16,792.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $16,792.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xiaflex 0.9 mg vials. The delivery order, awarded on December 3, 2025, with an ultimate completion date of December 24, 2025, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group Inc. competed for this requirement based on its established capability to supply specialized pharmaceutical products to Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply across multiple regional prime vendor contractors supporting worldwide Department of Defense healthcare operations. DMS Pharmaceutical Group's role as a prime vendor contractor authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support recurring medical supply requirements across military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DR26FCFL7?
SPE2DR26FCFL7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FCFL7 worth?
The government has obligated $16,793 on SPE2DR26FCFL7.
Is contract SPE2DR26FCFL7 an order under another contract?
Yes. SPE2DR26FCFL7 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFL7 competed?
The extent of competition for SPE2DR26FCFL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award